MacroGenics Inc (MGNX) income statement
MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.97−0.08 (-3.90%)
Close on Nov 18, 2026Market cap $125.49MP/E –Yield –
MacroGenics Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 89.2%
- Operating margin
- -24.3%
- Net margin
- -8.7%
- Return on equity, FY2025
- -86.9%
Financial strength
- Current ratio
- 2.96
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 104.7%
Valuation
- P/E ratio
- –
- Price to sales
- 0.75
- Price to book
- 2.93
- Dividend yield
- –
See a number that looks wrong?